Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Vaginal cancer statistics
Cancer Research UK supports GPs to deliver best practice. We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.
New cases of vaginal cancer, 2016-2018, UK
Deaths from vaginal cancer, 2016-2018, UK.
Vaginal cancer cases are preventable, UK, 2015
- There are around 250 new vaginal cancer cases in the UK every year, that's around 5 every week (2016-2018).
- In females in the UK, vaginal cancer is not among the 20 most common cancers, with around 250 new cases every year (2016-2018).
- Vaginal cancer accounts for less than 1% of all new cancer cases in females in the UK (2016-2018).
- Vaginal cancer accounts for less than 1% of all new cancer cases in females and males combined in the UK (2016-2018).
- Incidence rates for vaginal cancer in the UK are highest in females aged 85 to 89 (2016-2018).
- Each year almost 4 in 10 (37%) of all new vaginal cancer cases in the UK are diagnosed in females aged 75 and over (2016-2018).
- Since the early 1990s, vaginal cancer incidence rates have remained stable in females in the UK (2016-2018).
- Over the last decade, vaginal cancer incidence rates have remained stable in females in the UK (2016-2018).
- Vaginal cancer incidence rates in England in females are 88% higher in the most deprived quintile compared with the least (2013-2017). Around 55 cases of vaginal cancer each year in England are linked with deprivation.
- An estimated 1,200 women who had previously been diagnosed with vaginal cancer were alive in the UK at the end of 2010.
- There are around 100 vaginal cancer deaths in the UK every year, that's around 2 every week (2016-2018).
- In females in the UK, vaginal cancer is not among the 20 most common causes of cancer death, with around 110 deaths in 2018.
- Vaginal cancer accounts for less than 1% of all cancer deaths in females in the UK (2018).
- Vaginal cancer accounts for less than 1% of all cancer deaths in females and males combined in the UK (2018).
- Mortality rates for vaginal cancer in the UK are highest in females aged 90+ (2016-2018).
- Each year around half of all vaginal cancer deaths (51%) in the UK are in females aged 75 and over (2016-2018).
- Since the early 1970s, vaginal cancer mortality rates have decreased by around half (49%) in females in the UK.
- Over the last decade, vaginal cancer mortality rates have remained stable in females in the UK.
- Vaginal cancer deaths in England are more common in females living in the most deprived areas.
- Vagina and vulva cancer survival in England is highest for women diagnosed aged under 50 years old (2009-2013).
- More than 8 in 10 women in England diagnosed with vagina or vulva cancer aged 15-49 survive their disease for five years or more, compared with almost 6 in 10 women diagnosed aged 70-89 (2009-2013).
- Five-year relative survival for vaginal and vulval cancer in women is above the European average in England but similar to the European average in Wales, Scotland and Northern Ireland.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 1 in 1,421 UK females will be diagnosed with vaginal cancer in their lifetime.
- 75% of vaginal cancer cases in the UK are preventable.
- 'Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62-day wait’ is met by all but Wales, Northern Ireland and only partly by Scotland for gynaecological cancers.
- Almost a fifth of vaginal cancer patients receive major surgical resection as part of their cancer treatment.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or
Join the conversation and follow @CRUKHCPs for news, updates and opinion.
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.